Czechia, Jan. 13 -- Czechia based ROCHE s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - CELLCEPT 2025. The value of the contract is worth 395800000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....